The Global Media Business Weekly

ICYMI: How Covid boosted pharma B2B

From October 2024: We must not be fooled by the way that investors toss around the word ‘data’ to justify business valuations. In this context, the word may not, of course, mean much more than its dic...

 

Premium content

This content is exclusive to Flashes & Flames members.

You can join our membership for £219/year. Find out more.